• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奎尼丁诱发的室性心动过速和心室颤动,未接受洋地黄治疗。

Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.

作者信息

Koster R W, Wellens H J

出版信息

Am J Cardiol. 1976 Oct;38(4):519-23. doi: 10.1016/0002-9149(76)90471-9.

DOI:10.1016/0002-9149(76)90471-9
PMID:970334
Abstract

Three cases are described with documented ventricular flutter and fibrillation during quinidine medication without concomitant digitalis therapy. In all three patients the arrhythmia developed while they were receiving moderate doses of quinidine. Although no changes in QRS width were observed after administration of quinidine, there was marked prolongation of the Q-T interval. The mechanism of development of ventricular flutter and fibrillation in patients taking quinidine may be similar to that in patients with the Q-T prolongation syndrome.

摘要

本文描述了3例在服用奎尼丁期间记录到室性扑动和颤动的病例,这些患者未同时接受洋地黄治疗。在所有3例患者中,心律失常均在接受中等剂量奎尼丁治疗时发生。虽然服用奎尼丁后QRS波宽度未观察到变化,但Q-T间期明显延长。服用奎尼丁患者发生室性扑动和颤动的机制可能与Q-T间期延长综合征患者相似。

相似文献

1
Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.奎尼丁诱发的室性心动过速和心室颤动,未接受洋地黄治疗。
Am J Cardiol. 1976 Oct;38(4):519-23. doi: 10.1016/0002-9149(76)90471-9.
2
Spontaneous ventricular flutter and fibrillation during quinidine medication.奎尼丁用药期间的自发性心室扑动和颤动。
Am Heart J. 1983 May;105(5):863-5. doi: 10.1016/0002-8703(83)90256-9.
3
Delayed repolarization syndrome.延迟复极综合征
Am J Med. 1983 Sep;75(3):393-401. doi: 10.1016/0002-9343(83)90339-x.
4
[Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].[β-N-六亚甲基亚氨基对丁氧基苯丙酮(TG-17)、新斯的明和奎尼丁对毒毛花苷K诱发的猫心律失常的抗心律失常作用]
Farmakol Toksikol. 1969 Sep-Oct;32(5):566-70.
5
Disopyramide-induced ventricular fibrillation.丙吡胺诱发的心室颤动。
Am J Cardiol. 1979 May;43(5):1053-5. doi: 10.1016/0002-9149(79)90374-6.
6
Treatment of cardiac arrhythmias.心律失常的治疗。
Med Lett Drugs Ther. 1974 Dec 6;16(25):101-8.
7
Prodromal ventricular premature beats preceded by a diastolic wave.
Acta Med Scand. 1980;208(6):445-50. doi: 10.1111/j.0954-6820.1980.tb01229.x.
8
[Ventricular fibrillation under quinidine medication--quinidine syncope (author's transl)].奎尼丁用药期间的心室颤动——奎尼丁晕厥(作者译)
Med Klin. 1978 Mar 3;73(9):325-8.
9
The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.奎尼丁在室性心律失常药物治疗中的作用——“奎尼丁”
Mini Rev Med Chem. 2018;18(6):468-475. doi: 10.2174/1389557517666170707110450.
10
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.抗心律失常药物治疗期间发生心室颤动患者的临床特征。
N Engl J Med. 1988 Aug 4;319(5):257-62. doi: 10.1056/NEJM198808043190501.

引用本文的文献

1
Adult Human Primary Cardiomyocyte-Based Model for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-arrhythmia Risk.用于同时预测药物诱导的变力性和促心律失常风险的成人人类原代心肌细胞模型
Front Physiol. 2017 Dec 19;8:1073. doi: 10.3389/fphys.2017.01073. eCollection 2017.
2
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes.先天性心律失常基因中的新型罕见变异与药物诱导尖端扭转型室性心动过速密切相关。
Pharmacogenomics J. 2013 Aug;13(4):325-9. doi: 10.1038/tpj.2012.14. Epub 2012 May 15.
3
Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.
最小化药物研发和临床实践中与复极相关的致心律失常风险。
Drugs. 2010 Mar 26;70(5):573-603. doi: 10.2165/11535230-000000000-00000.
4
Cellular basis of drug-induced torsades de pointes.药物诱导的尖端扭转型室性心动过速的细胞基础。
Br J Pharmacol. 2008 Aug;154(7):1502-7. doi: 10.1038/bjp.2008.238. Epub 2008 Jun 16.
5
Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.持续性心房颤动与药物诱导的长QT综合征患者发生尖端扭转型室速的风险降低相关。
J Am Coll Cardiol. 2008 Feb 26;51(8):836-42. doi: 10.1016/j.jacc.2007.09.066.
6
On the relationship among QT interval, atrial fibrillation, and torsade de pointes.关于QT间期、心房颤动和尖端扭转型室性心动过速之间的关系。
Europace. 2007 Sep;9 Suppl 4(Suppl 4):iv1-3. doi: 10.1093/europace/eum165.
7
A practical approach to torsade de pointes.一种治疗尖端扭转型室速的实用方法。
Clin Cardiol. 1997 Mar;20(3):285-90. doi: 10.1002/clc.4960200318.
8
Drug-induced torsade de pointes. Incidence, management and prevention.药物性尖端扭转型室性心动过速。发病率、管理与预防。
Drug Saf. 1994 Dec;11(6):463-76. doi: 10.2165/00002018-199411060-00007.
9
Hyperventilation versus bicarbonate therapy for alkalinization in tricyclic antidepressant overdose.三环类抗抑郁药过量时,过度通气与碳酸氢盐疗法用于碱化治疗的比较。
West J Med. 1981 Aug;135(2):160-1.
10
Torsades de pointes, a common arrhythmia, induced by medication.尖端扭转型室性心动过速,一种常见的心律失常,由药物诱发。
Can Med Assoc J. 1982 Sep 1;127(5):368-72.